AMANDA MARTIN: Open Payments
NPI 1801061361 · WEST END, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,812 in 147 payments from 17 companies in 2025. Trend: 2023 $1,994 · 2024 $2,390 · 2025 $2,812
Food & beverage: $2,361Education: $451
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $459 |
| GENZYME CORPORATION | 15 | $388 |
| ABBVIE INC. | 25 | $382 |
| Novartis Pharmaceuticals Corporation | 16 | $205 |
| Regeneron Healthcare Solutions, Inc. | 8 | $203 |
| PFIZER INC. | 12 | $172 |
| E.R. Squibb & Sons, L.L.C. | 7 | $167 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $150 |
| Arcutis Biotherapeutics, Inc. | 12 | $149 |
| UCB, Inc. | 9 | $141 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Sotyktu, CIBINQO, Zoryve, Bimzelx.
Industry payments across NC — which companies pay providers there.
